BioCentury
ARTICLE | Company News

Abbott, Par Pharmaceutical, Perrigo, Watson endocrine/metabolic news

December 17, 2012 8:00 AM UTC

The U.S. Supreme Court agreed to review a decision from the U.S. Court of Appeals for the Eleventh Circuit that upheld a pay-for-delay deal between branded and generic drug manufacturer as not in viol...